Fisher & Paykel Healthcare Corporation Limited's latest marketcap:
As of 07/05/2025, Fisher & Paykel Healthcare Corporation Limited's market capitalization has reached $13 B. According to our data, Fisher & Paykel Healthcare Corporation Limited is the 1544th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 13 B |
| Revenue (ttm) | 1.22 B |
| Net Income (ttm) | 228.62 M |
| Shares Out | 586.27 M |
| EPS (ttm) | 0.39 |
| Forward PE | 49.92 |
| Ex-Dividend Date | 06/23/2025 |
| Earnings Date | 11/26/2025 |
Fisher & Paykel Healthcare Corporation Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | NZ$13 B | -5.18% | 1544 |
| 12/31/2024 | NZ$22.51 B | 63.32% | 1408 |
| 12/29/2023 | NZ$13.78 B | 5.28% | 1827 |
| 12/30/2022 | NZ$13.09 B | -30.76% | 1754 |
| 12/31/2021 | NZ$18.91 B | -0.45% | 1471 |
| 12/31/2020 | NZ$18.99 B | 48.92% | 1231 |
| 12/31/2019 | NZ$12.75 B | 71.02% | 1533 |
| 12/31/2018 | NZ$7.46 B | -8.94% | 2015 |
| 12/29/2017 | NZ$8.19 B | 69.54% | 2077 |
| 12/30/2016 | NZ$4.83 B | -3.58% | 2669 |
Company Profile
About Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems globally, with operations in North America, Europe, the Asia Pacific, and other international markets.
Product Offerings
- Acute & Chronic Respiratory Care: Solutions for both hospital and home use, including treatments for obstructive sleep apnea (OSA).
- Adult Respiratory Products: Features Optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.
- Infant Respiratory Products: Includes resuscitation, invasive ventilation, CPAP therapy, and nasal high flow therapy.
- Hospital Products: Humidification systems, breathing circuits, masks, nasal cannulas, surgical accessories, and interfaces.
- Homecare Products: CPAP devices, masks, humidifiers, and software for data management.
Company Background
Founded in 1934, Fisher & Paykel Healthcare Corporation Limited is headquartered in Auckland, New Zealand.
Frequently Asked Questions
-
What is Fisher & Paykel Healthcare Corporation Limited's (NZE-FPH) current market cap?As of 07/05/2025, Fisher & Paykel Healthcare Corporation Limited (including the parent company, if applicable) has an estimated market capitalization of $13 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Fisher & Paykel Healthcare Corporation Limited (NZE-FPH) rank globally by market cap?Fisher & Paykel Healthcare Corporation Limited global market capitalization ranking is approximately 1544 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.